Pivotal Study of the Medtronic Axys EX Rotational Atherectomy System
NCT04282161 is an interventional trial sponsored by Medtronic Endovascular. As of 18 Nov 2026, it was withdrawn. It studies Peripheral Arterial Disease. The registry lists an enrollment of 0 participants. The registry lists a start date of 31 Dec 2021 and a primary completion date of 31 Aug 2023.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT04282161 |
| Status | Withdrawn |
| Study type | Interventional trial |
| Lead sponsor | Medtronic Endovascular |
| Enrollment | 0 |
| Conditions | Peripheral Arterial Disease |
| Start | 31 Dec 2021 |
| Primary completion | 31 Aug 2023 |
| Study completion | 29 Feb 2024 |
| Last update posted | 5 Apr 2021 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Brian DeRubertis, MD FACS
University of California, Los Angeles
Principal Investigator - Ravish Sachar, MD FACC
North Carolina Heart and Vascular
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT04282161
Each answer restates registry values shown on this page.
What is NCT04282161?
NCT04282161 is an interventional trial sponsored by Medtronic Endovascular. It studies Peripheral Arterial Disease.
Who leads NCT04282161?
The registry names Brian DeRubertis, MD FACS (principal investigator, University of California, Los Angeles) and Ravish Sachar, MD FACC (principal investigator, North Carolina Heart and Vascular) as overall officials.
When did NCT04282161 end?
The registry lists a primary completion date of 31 Aug 2023 and a study completion date of 29 Feb 2024. The sponsor last updated the record on 5 Apr 2021.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.